ArticleBMC surgery2009

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.

Andre Mihaljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.